Mesoblast Company Update - Webcast and Forward Thoughts, page-4

  1. 249 Posts.
    lightbulb Created with Sketch. 585
    Great Analysis,

    Listening to SI on the webcast this morning, sounds like they are only going to move forward with a randomised Ryoncil trial for Adults with aGVHD only if we have an accelerated approval path for pediatric aGVHD, so in effect, we can't continue without some commitment/support from the FDA including outcomes from the RemL 300 patient Trial for COVID ARDS. Don't blame MSB for taking this approach, enough is enough with these ultra conservative FDA morons.

    Last edited by JSBStrikesBack: 02/10/20
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.65
Change
0.070(4.44%)
Mkt cap ! $2.095B
Open High Low Value Volume
$1.58 $1.65 $1.58 $5.674M 3.508M

Buyers (Bids)

No. Vol. Price($)
18 45219 $1.64
 

Sellers (Offers)

Price($) Vol. No.
$1.65 88888 35
View Market Depth
Last trade - 15.04pm 10/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.